cloprostenol 🐶 Veterinary Use | Indications/Contra | FAERs-F | FAERs-M | Orange Bk | PK/Tox | Related Drugs | BioActivity |

Stem definitionDrug idCAS RN
prostaglandins 5665 40665-92-7

Description:

MoleculeDescription

Molfile Inchi Smiles

Synonyms:

  • cloprostenol
  • racemic cloprostenol
  • cloprostenol sodium
A synthetic prostaglandin F2alpha analog. The compound has luteolytic effects and is used for the synchronization of estrus in cattle
  • Molecular weight: 424.92
  • Formula: C22H29ClO6
  • CLOGP: 2.43
  • LIPINSKI: 0
  • HAC: 6
  • HDO: 4
  • TPSA: 107.22
  • ALOGS: -4.10
  • ROTB: 11

Drug dosage:

None

ADMET properties:

None

Predicted pharmacokinetic/toxicological properties (PK-AZ):

PropertyDescriptionValueUnitConfidenceSimilarity
pfas-class PFAS structural alert (1 = True, 0 = False) 0

Approvals:

DateAgencyCompanyOrphan
None FDA

FDA Adverse Event Reporting System (Female)

None

FDA Adverse Event Reporting System (Male)

None

FDA Adverse Event Reporting System (Geriatric)

None

FDA Adverse Event Reporting System (Pediatric)

None

Pharmacologic Action:

SourceCodeDescription
MeSH PA D000080066 Contraceptive Agents, Hormonal
MeSH PA D003271 Contraceptive Agents, Female
MeSH PA D008186 Luteolytic Agents
MeSH PA D012102 Reproductive Control Agents

Drug Use | Suggest Off label Use Form| |View source of the data|

None




🐶 Veterinary Drug Use

SpeciesUseRelation
Cattle Induction of luteolysis Indication
Cattle Estrus and ovulation programming interruption of unwanted pregnancies caused by incorrect pairings Indication
Cattle Treatment of unobserved estrus (undetected) Indication
Cattle Treatment of mummified fetus Indication
Cattle Treatment of luteal cysts Indication
Cattle Pyometra treatment Indication

🐶 Veterinary products

ProductApplicantIngredients
Estrumate, Heifex Intervet Inc. 1
estroPLAN Injection Parnell Technologies Pty. Ltd. 1

Acid dissociation constants calculated using MoKa v3.0.0

None

Orange Book patent data (new drug applications)

None

Orange Book exclusivity data (new drug applications)

None

Bioactivity Summary:

TargetClassPharosUniProtActionTypeActivity value
(-log[M])
Mechanism
action
Bioact sourceMoA source
Prostaglandin E2 receptor EP1 subtype GPCR IC50 6.30 CHEMBL
Prostaglandin E2 receptor EP3 subtype GPCR AGONIST Ki 8.36 IUPHAR
Prostaglandin E2 receptor EP2 subtype GPCR IC50 5.43 CHEMBL
Prostaglandin F2-alpha receptor GPCR IC50 9 CHEMBL

External reference:

IDSource
CHEBI:177470 CHEBI
CHEMBL2220404 ChEMBL_ID
1894 IUPHAR_LIGAND_ID
DB11507 DRUGBANK_ID
763009004 SNOMEDCT_US
96352000 SNOMEDCT_US
C0009030 UMLSCUI
D003008 MESH_DESCRIPTOR_UI
A1D5A PDB_CHEM_ID
CHEMBL2218867 ChEMBL_ID
3793 INN_ID
55028-72-3 SECONDARY_CAS_RN
D07730 KEGG_DRUG
5311053 PUBCHEM_CID
4208238832 UNII
204179 RXNORM

Pharmaceutical products:

None